| |
| |
|
| Insider
Information: |
Martin John C |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,895,138 |
|
|
Indirect Shares
|
2,684,281 |
|
|
| Direct
Value |
$189,361,486 |
|
|
|
Indirect Value
|
$47,757,584 |
|
|
| Total
Shares |
5,579,419 |
|
|
| Total
Value |
$237,119,070 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-07-08 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,620,229 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-07-08 |
4 |
S |
$52.69 |
$3,699,993 |
D/D |
(70,000) |
1,550,229 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-08-12 |
4 |
S |
$56.82 |
$3,977,729 |
D/D |
(70,000) |
1,550,229 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2008-08-12 |
4 |
OE |
$3.65 |
$255,395 |
D/D |
70,000 |
1,620,229 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chairman and CEO |
• • – |
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
1,666,718 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-02-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,204,429 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-02-01 |
4 |
AS |
$72.57 |
$5,322,069 |
D/D |
(73,333) |
3,131,096 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-03-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,199,969 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-03-01 |
4 |
AS |
$70.38 |
$5,161,206 |
D/D |
(73,333) |
3,126,636 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-04-03 |
4 |
AS |
$67.07 |
$4,926,287 |
D/D |
(73,333) |
3,126,636 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-04-03 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,199,969 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-05-01 |
4 |
AS |
$68.31 |
$5,009,429 |
D/D |
(73,333) |
3,126,636 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-05-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,199,969 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-06-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,273,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-06-01 |
4 |
AS |
$65.24 |
$4,784,531 |
D/D |
(73,333) |
3,199,969 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-07-03 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,199,969 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-07-03 |
4 |
AS |
$71.00 |
$5,206,892 |
D/D |
(73,333) |
3,126,636 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-08-01 |
4 |
AS |
$75.86 |
$5,562,777 |
D/D |
(73,333) |
3,126,636 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-08-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,199,969 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-09-01 |
4 |
AS |
$83.03 |
$6,094,992 |
D/D |
(73,333) |
2,996,766 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-09-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,070,099 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-10-02 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,070,099 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-10-02 |
4 |
AS |
$81.82 |
$6,054,319 |
D/D |
(73,333) |
2,996,766 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-11-01 |
4 |
AS |
$75.08 |
$5,509,697 |
D/D |
(73,333) |
2,996,766 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Executive Chairman |
• • – |
2017-11-01 |
4 |
OE |
$21.58 |
$1,582,159 |
D/D |
73,333 |
3,070,099 |
0 |
- |
|
367 Records found
|
|
Page 6 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
